Skip to content

APOTHEEK KEYMOLEN

Active
Private limited companyfounded 199530 yrs activeHooigaardestraat 1, 1800 Vilvoorde, BelgiumKBO/BCE: BE 0456.560.291
Summary

APOTHEEK KEYMOLEN has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €610k and a net result of €143k. Equity is growing by ~17.7% per year across the filed fiscal years. Its solvency ranks better than 78% of 9623 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2024
76 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability88=
Solvency90▼-2
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity ample (current ratio 2.82 against 2.86 in 2023; short-term debt: 33.3% and cash: 14.7% of total assets), and 34.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 30 years 0 40 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
65.4%
Return on assets
15.3%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-07-2025, 3 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
3 d early
2023
2 d early
2022
4 d early
2021
23 d late
2020
24 d late
2019
12 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€610k▲ 17.8%
2023 · €517k
2018: €258k 2019: €270k 2020: €265k 2021: €316k 2022: €422k 2023: €517k
2018 → 2024
Total assets
€933k▲ 20.4%
2023 · €775k
2018: €467k 2019: €512k 2020: €611k 2021: €607k 2022: €664k 2023: €775k
2018 → 2024
Net result
€143k▲ 17.4%
2023 · €122k
2018: €26k 2019: €51k 2020: €95k 2021: €97k 2022: €106k 2023: €122k
2018 → 2024
Working capital
€565k▲ 22.6%
2023 · €461k
2018: €195k 2019: €196k 2020: €179k 2021: €241k 2022: €355k 2023: €461k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€265k-€316k▲ 19.3%€422k▲ 33.5%€517k▲ 22.7%€610k▲ 17.8%
Operating result€140k-€144k▲ 2.6%€161k▲ 11.9%€179k▲ 11.6%€199k▲ 11.1%
Net result€95k-€97k▲ 2.2%€106k▲ 9.0%€122k▲ 15.0%€143k▲ 17.4%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150k€200kOperating result 2020: €140k€140kNet result 2020: €95k€95kOperating result 2021: €144k€144kNet result 2021: €97k€97kOperating result 2022: €161k€161kNet result 2022: €106k€106kOperating result 2023: €179k€179kNet result 2023: €122k€122kOperating result 2024: €199k€199kNet result 2024: €143k€143k20202021202220232024€0€50k€100k€150k€200kOperating result 2022: €161k€161kNet result 2022: €106k€106kOperating result 2023: €179k€179kNet result 2023: €122k€122kOperating result 2024: €199k€199kNet result 2024: €143k€143k202220232024
The operating result has risen four years in a row; 2024 is 11% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €933k
Fixed assets €57k ▼ 12.3%
Current assets €875k ▲ 23.4%
Equity and liabilities €933k
Equity €610k ▲ 17.8%
Debt €323k ▲ 25.7%
Debt's share of the balance-sheet total rises from 33.2% to 34.6%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€211k
2023 · €190k
Cash flow
€155k
2023 · €132k
Current ratio
2.82
2023 · 2.86
Quick ratio
2.38
2023 · 2.38
Debt to equity
0.53
2023 · 0.50
ROE
23.4%
2023 · 23.5%
ROA
15.3%
2023 · 15.7%
Interest coverage
14.69
2023 · 18.34
Debt ≤ 1 year
€310k
2023 · €248k
Income taxes
€53k
2023 · €51k
Staff costs
€70k
2023 · €68k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 49 lines
Balance sheet Code20232024
Assets
Total assets20/58€775k€933k
Fixed assets21/28€65k€57k
Tangible fixed assets22/27€65k€57k
Land and buildings22€48k€44k
Plant, machinery and equipment23€14k€11k
Furniture and vehicles24€4k€3k
Current assets29/58€709k€875k
Stocks and contracts in progress3€117k€137k
Stocks30/36€117k€137k
Amounts receivable within one year40/41€63k€77k
Trade receivables40€63k€77k
Current investments50/53€376k€508k
Cash at bank and in hand54/58€136k€137k
Deferred charges and accrued income490/1€17k€17k
Equity and liabilities
Total equity and liabilities10/49€775k€933k
Equity10/15€517k€610k
Contributions10/11€19k€19k=
Reserves13€499k€591k
Distributable reserves133€499k€591k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€257k€323k
Amounts payable within one year42/48€248k€310k
Trade debts44€33k€61k
Suppliers440/4€33k€61k
Taxes, remuneration and social security45€32k€35k
Taxes450/3€24k€22k
Remuneration and social security454/9€8k€13k
Other amounts payable47/48€183k€214k
Accrued charges and deferred income492/3€9k€13k
Income statement Code20232024
Remuneration, social security and pensions62€68k€70k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€12k
Other operating charges640/8€265€267
Gross operating margin9900€258k€281k
Operating profit (loss)9901€179k€199k
Financial income75/76B€4k€11k
Recurring financial income75€4k€11k
Financial charges65/66B€10k€14k
Recurring financial charges65€10k€14k
Profit (loss) for the period before taxes9903€173k€196k
Income taxes67/77€51k€53k
Profit (loss) for the period9904€122k€143k
Profit (loss) for the period to be appropriated9905€122k€143k
Appropriation of the result
Profit (loss) to be appropriated9906€122k€143k
Transfer from equity791/2€26k€51k
Transfer to equity691/2€122k€143k
To other reserves6921€122k€143k
Profit to be distributed694/7€26k€51k
Return on contributions (dividend)694€26k€51k
Social balance
Average headcount (FTE)90870.90.9=

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
28-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Highest result since 2018net €143k ▲17.4%
Operating result €199k, net result €143k, both a record.
29-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Equity above €500kEq €517k ▲22.7%
6 profitable years in a row build equity to €517k.
27-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
23-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 23 days late
2021
24-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
2020
12-08
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 12 days late
2019
14-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 14 days late
2018
07-08
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 7 days late
2017
22-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 22 days late
2016
21-07
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Vilvoorde · 1 establishment unit since 1995
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Hooigaardestraat 11800 Vilvoorde
Ground area
523 m²
Building footprint
194 m²
Volume, LiDAR
1,214 m³
Parcel 23643G0015/00D000, Flanders · tallest building 8.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Hooigaardestraat 1, 1800 Vilvoorde
Warehousing and support activities for transportation
since 19952.074.320.551
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23643G0015/00D000 Flanders 523 m² 1 · 193 m² 8.3 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Vilvoorde2.074.320.551
1 permission
Apotheek (LM>3 maand) · since 04-09-2006

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,287 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded04-12-1995
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 29 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.